17b hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma (English)
- New search for: Szajnik, M.
- New search for: Szczepanski, M. J.
- New search for: Elishaev, E.
- New search for: Visus, C.
- New search for: Lenzner, D.
- New search for: Zabel, M.
- New search for: Glura, M.
- New search for: DeLeo, A. B.
- New search for: Whiteside, T. L.
- New search for: Szajnik, M.
- New search for: Szczepanski, M. J.
- New search for: Elishaev, E.
- New search for: Visus, C.
- New search for: Lenzner, D.
- New search for: Zabel, M.
- New search for: Glura, M.
- New search for: DeLeo, A. B.
- New search for: Whiteside, T. L.
In:
GYNECOLOGIC ONCOLOGY
;
127
, 3
;
587-594
;
2012
-
ISSN:
- Article (Journal) / Print
-
Title:17b hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma
-
Contributors:Szajnik, M. ( author ) / Szczepanski, M. J. ( author ) / Elishaev, E. ( author ) / Visus, C. ( author ) / Lenzner, D. ( author ) / Zabel, M. ( author ) / Glura, M. ( author ) / DeLeo, A. B. ( author ) / Whiteside, T. L. ( author )
-
Published in:GYNECOLOGIC ONCOLOGY ; 127, 3 ; 587-594
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam
-
Publication date:2012-01-01
-
Size:8 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.992
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.992 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 127, Issue 3
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 437
-
Optimizing cervical cancer prevention strategies in the United StatesCastle, P. E. / Schmeler, K. M. et al. | 2012
- 440
-
Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trialfor, t. H. / Roset Bahmanyar, E. / Paavonen, J. / Naud, P. / Salmeron, J. / Chow, S. N. / Apter, D. / Kitchener, H. / Castellsague, X. / Teixeira, J. C. et al. | 2012
- 451
-
Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group studyAlberts, D. S. / Blessing, J. A. / Landrum, L. M. / Warshal, D. P. / Martin, L. P. / Rose, S. L. / Bonebrake, A. J. / Ramondetta, L. M. et al. | 2012
- 456
-
A phase I trial of tailored radiation therapy with concomitant cetuximab and cisplatin in the treatment of patients with cervical cancer: A gynecologic oncology group studyMoore, K. N. / Sill, M. W. / Miller, D. S. / McCourt, C. / De Geest, K. / Rose, P. G. / Cardenes, H. R. / Mannel, R. S. / Farley, J. H. / Schilder, R. J. et al. | 2012
- 462
-
Bilateral ultrastaging of sentinel lymph node in cervical cancer: Lowering the false-negative rate and improving the detection of micrometastasisCibula, D. / Abu-Rustum, N. R. / Dusek, L. / Slama, J. / Zikan, M. / Zaal, A. / Sevcik, L. / Kenter, G. / Querleu, D. / Jach, R. et al. | 2012
- 467
-
''Triple injection'' lymphatic mapping technique to determine if parametrial nodes are the true sentinel lymph nodes in women with cervical cancerFrumovitz, M. / Euscher, E. D. / Deavers, M. T. / Soliman, P. T. / Schmeler, K. M. / Ramirez, P. T. / Levenback, C. F. et al. | 2012
- 472
-
Outcomes and prognosis of patients with recurrent cervical cancer after radical hysterectomyQiu, J. T. / Abdullah, N. A. / Chou, H. H. / Lin, C. T. / Jung, S. M. / Wang, C. C. / Chen, M. Y. / Huang, K. G. / Chang, T. C. / Lai, C. H. et al. | 2012
- 478
-
The mean apparent diffusion coefficient value (ADCmean) on primary cervical cancer is a predictive marker for disease recurrenceNakamura, K. / Joja, I. / Nagasaka, T. / Fukushima, C. / Kusumoto, T. / Seki, N. / Hongo, A. / Kodama, J. / Hiramatsu, Y. et al. | 2012
- 484
-
Reproducibility and accuracy of robot-assisted laparoscopic fertility sparing radical trachelectomyPersson, J. / Imboden, S. / Reynisson, P. / Andersson, B. / Borgfeldt, C. / Bossmar, T. et al. | 2012
- 489
-
Interaction of epithelial biomarkers, local immune response and condom use in cervical intraepithelial neoplasia 2-3 regressionMunk, A. C. / Gudlaugsson, E. / Ovestad, I. T. / Lovslett, K. / Fiane, B. / Hidle, B. v. / Kruse, A. J. / Skaland, I. / Janssen, E. A. / Baak, J. P. et al. | 2012
- 495
-
Cytokine use and survival in the first-line treatment of ovarian cancer: A Gynecologic Oncology Group StudyStehman, F. B. / Brady, M. F. / Thigpen, J. T. / Rossi, E. C. / Burger, R. A. et al. | 2012
- 502
-
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-upFagotti, A. / Costantini, B. / Petrillo, M. / Vizzielli, G. / Fanfani, F. / Margariti, P. A. / Turco, L. C. / Piovano, E. / Scambia, G. et al. | 2012
- 506
-
A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group studyGould, N. / Sill, M. W. / Mannel, R. S. / Thaker, P. H. / DiSilvestro, P. A. / Waggoner, S. E. / Yamada, S. D. / Armstrong, D. K. / Fracasso, P. M. / Walker, J. L. et al. | 2012
- 511
-
Human epididymis protein 4 (HE4) and ovarian cancer prognosisTrudel, D. / Tetu, B. / Gregoire, J. / Plante, M. / Renaud, M. C. / Bachvarov, D. / Douville, P. / Bairati, I. et al. | 2012
- 516
-
Histopathologic features of ovarian borderline tumors are not predictive of clinical outcomeAvril, S. / Hahn, E. / Specht, K. / Hauptmann, S. / Hoss, C. / Kiechle, M. / Hofler, H. / Schmalfeldt, B. et al. | 2012
- 525
-
A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancerKumar, S. / Medeiros, F. / Dowdy, S. C. / Keeney, G. L. / Bakkum-Gamez, J. N. / Podratz, K. C. / Cliby, W. A. / Mariani, A. et al. | 2012
- 532
-
Ultrastaging of para-aortic lymph nodes in stage IIIC1 endometrial cancer: A preliminary reportTodo, Y. / Suzuki, Y. / Azuma, M. / Hatanaka, Y. / Konno, Y. / Watari, H. / Kato, H. / Matsuno, Y. / Yamashiro, K. / Sakuragi, N. et al. | 2012
- 538
-
A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group studyColeman, R. L. / Sill, M. W. / Lankes, H. A. / Fader, A. N. / Finkler, N. J. / Hoffman, J. S. / Rose, P. G. / Sutton, G. P. / Drescher, C. W. / McMeekin, D. S. et al. | 2012
- 544
-
Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndromeYurgelun, M. B. / Mercado, R. / Rosenblatt, M. / Dandapani, M. / Kohlmann, W. / Conrad, P. / Blanco, A. / Shannon, K. M. / Chung, D. C. / Terdiman, J. et al. | 2012
- 552
-
Loss of function germline mutations in RAD51D in women with ovarian carcinomaWickramanyake, A. / Bernier, G. / Pennil, C. / Casadei, S. / Agnew, K. J. / Stray, S. M. / Mandell, J. / Garcia, R. L. / Walsh, T. / King, M. C. et al. | 2012
- 556
-
Psychological outcomes of familial ovarian cancer screening: No evidence of long-term harmBrain, K. E. / Lifford, K. J. / Fraser, L. / Rosenthal, A. N. / Rogers, M. T. / Lancastle, D. / Phelps, C. / Watson, E. K. / Clements, A. / Menon, U. et al. | 2012
- 564
-
Identification of the optimal pathway to reach an accurate diagnosis in the absence of an early detection strategy for ovarian cancerHess, L. M. / Stehman, F. B. / Method, M. W. / Weathers, T. D. / Gupta, P. / Schilder, J. M. et al. | 2012
- 569
-
Combined expression of KLK4, KLK5, KLK6, and KLK7 by ovarian cancer cells leads to decreased adhesion and paclitaxel-induced chemoresistanceLoessner, D. / Quent, V. M. / Kraemer, J. / Weber, E. C. / Hutmacher, D. W. / Magdolen, V. / Clements, J. A. et al. | 2012
- 579
-
Romidepsin (FK228) combined with cisplatin stimulates DNA damage-induced cell death in ovarian cancerWilson, A. J. / Lalani, A. S. / Wass, E. / Saskowski, J. / Khabele, D. et al. | 2012
- 587
-
17b hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinomaSzajnik, M. / Szczepanski, M. J. / Elishaev, E. / Visus, C. / Lenzner, D. / Zabel, M. / Glura, M. / DeLeo, A. B. / Whiteside, T. L. et al. | 2012
- 595
-
Detection of PAX8 and p53 is beneficial in recognizing metastatic carcinomas in pelvic washings, especially in cases with suspicious cytologyXiang, L. / Zheng, W. / Kong, B. et al. | 2012
- 601
-
FOXM1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancerHe, S. y. / Shen, H. w. / Xu, L. / Zhao, X. h. / Yuan, L. / Niu, G. / You, Z. S. / Yao, S. z. et al. | 2012
- 611
-
Age-specific trends in black-white disparities in cervical cancer incidence in the United States: 1975-2009Simard, E. P. / Naishadham, D. / Saslow, D. / Jemal, A. et al. | 2012
- 616
-
Histopathologic differences account for racial disparity in uterine cancer survivalSmotkin, D. / Nevadunsky, N. S. / Harris, K. / Einstein, M. H. / Yu, Y. / Goldberg, G. L. et al. | 2012
- 620
-
Five-year trends in mortality indices among gynecological cancer patients in CanadaAkhtar-Danesh, N. / Lytwyn, A. / Elit, L. et al. | 2012
- 625
-
Risk of second primary malignancies in women with cervical cancer: A population-based study in Taiwan over a 30-year periodChen, C. Y. / Lai, C. H. / Lee, K. D. / Huang, S. H. / Dai, Y. M. / Chen, M. C. et al. | 2012
- 631
-
Prolonged postoperative venous thrombo-embolism prophylaxis is cost-effective in advanced ovarian cancer patientsUppal, S. / Hernandez, E. / Dutta, M. / Dandolu, V. / Rose, S. / Hartenbach, E. et al. | 2012
- 638
-
Would complex decongestive therapy reveal long term effect and lymphoscintigraphy predict the outcome of lower-limb lymphedema related to gynecologic cancer treatment?Kim, Y. B. / Hwang, J. H. / Kim, T. W. / Chang, H. J. / Lee, S. G. et al. | 2012
- 643
-
Extraperitoneal para-aortic lymphadenectomy: Laparoscopic single port approachTateo, S. / Mereu, L. / Mencaglia, L. et al. | 2012
- 644
-
Robotic single port total laparoscopic hysterectomy for endometrial cancer patientsMereu, L. / Carri, G. / Khalifa, H. et al. | 2012
- 645
-
New views on the pathogenesis of high-grade pelvic serous carcinoma with suggestions for advancing future researchSherman, M. E. / Guido, R. / Wentzensen, N. / Yang, H. P. / Mai, P. L. / Greene, M. H. et al. | 2012
- 651
-
Uterine papillary serous cancer: A review of the literaturedel Carmen, M. G. / Birrer, M. / Schorge, J. O. et al. | 2012
- 662
-
mTOR inhibitors in breast cancer: A systematic reviewZagouri, F. / Sergentanis, T. N. / Chrysikos, D. / Filipits, M. / Bartsch, R. et al. | 2012
- 673
-
Role of estrogen receptor b in gynecological cancerHaring, J. / Schuler, S. / Lattrich, C. / Ortmann, O. / Treeck, O. et al. | 2012
- 677
-
Location of aortic node metastases in locally advanced cervical cancerGil-Moreno, A. / Magrina, J. F. et al. | 2012
- 677
-
Paraaortic lymphatic spread in cervical cancerHockel, M. / Einenkel, J. / Horn, L. C. et al. | 2012
- 678
-
Re: ''The utilization of palliative care in gynecologic oncology patients near the end of life''Barnett, J. C. / Leath, C. A. et al. | 2012
- 679
-
End-of-life discussions in patients with gynecologic malignancies: How do we best handle it?Fauci, J. / Straughn, J. M. et al. | 2012
- 680
-
Corrigendum to ''RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer'' [Gynecol. Oncol. 124 (2012) 589-597]Vishnu, P. / Colon-Otero, G. / Kennedy, G. T. / Marlow, L. A. / Kennedy, W. P. / Wu, K. J. / Santoso, J. T. / Copland, J. A. et al. | 2012
-
Editorial Board| 2012